Chromosome instability in cancer: How, when, and why?

Advances in Cancer Research

Volumn 87, Issue , 2003, Pages 1-29

  Gisselsson, David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

BREAST CARCINOMA; CANCER; CANCER GENETICS; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; CYTOGENETICS; DNA DAMAGE; DNA STRAND BREAKAGE; GENE AMPLIFICATION; GENOME; HEAD AND NECK CARCINOMA; HETEROCHROMATIN; HUMAN; KARYOTYPE; NONHUMAN; OSTEOSARCOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; TELOMERE; TUMOR GROWTH;

EID: 0037288474     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(03)87164-6     Document Type: Review

References (132)

1. Agapova, L. S., Ilyinskaya, G. V., Turovets, N. A., Ivanov, A. V., Chumakov, P. M., and Kopnin, B. P. (1996). Chromosome changes caused by alterations of p53 expression. Mutat. Res. 354, 129-138.
2. Agapova, L. S., Ivanov, A. V., Sablina, A. A., Kopnin, P. B., Sokova, O. I., Chumakov, P. M., and Kopnin, B. P. (1999). P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene 18, 3135-3142.
3. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. (2000). Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645.
4. Artandi, S. E., and DePinho, R. A. (2000). A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39-46.
5. Baisse, B., Bouzourene, H., Saraga, E. P., Bosman, F. T., and Benhattar, J. (2001). Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int. J. Cancer 93, 346-352.
6. Bednarek, A. K., Keck-Waggoner, C. L., Daniel, R. L., Laflin, K. J., Bergsagel, P. L., Kiguchi, K., Brenner, A. J., and Aldaz, C. M. (2001). WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res. 61, 8068-8073.
7. Bednarek, A. K., Laflin, K. J., Daniel, R. L., Liao, Q., Hawkins, K. A., and Aldaz, C. M. (2000). WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 60, 2140-2145.
8. Berner, J. M., Forus, A., Elkahloun, A., Meltzer, P. S., Fodstad, Ø., and Myklebost, O. (1996). Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer 17, 254-259.
9. Berner, J. M., Meza-Zepeda, L. A., Kools, P. F., Forus, A., Schoenmakers, E. F., Van de Ven, W. J., Fodstad, Ø., and Myklebost, O. (1997). HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene 14, 2935-2941.
10. Boveri, T. (1914). "Zur Frage der Entstehung maligner Tumoren." Verlag von Gustav Fischer, Jena.
11. Bunz, F., Fauth, C., Speicher, M. R., Dutriaux, A., Sedivy, J. M., Kinzler, K. W., Vogelstein, B., and Lengauer, C. (2002). Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res. 62, 1129-1133.
12. Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. (1998). Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300-303.
13. Carroll, P. E., Okuda, M., Horn, H. F., Biddinger, P., Stambrook, P. J., Gleich, L. L., Li, Y. Q., Tarapore, P., and Fukasawa, K. (1999). Centrosome hyperamplification in human cancer: Chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 18, 1935-1944.
14. Chernova, O. B., Chernov, M. V., Agarwal, M. L., Taylor, W. R., and Stark, G. R. (1995). The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 20, 431-434.
15. Chernova, O. B., Chernov, M. V., Ishizaka, Y., Agarwal, M. L., and Stark, G. R. (1998). MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification. Mol. Cell. Biol. 18, 536-545.
16. Cohen-Jonathan, E., Bernhard, E. J., and McKenna, W. G. (1999). How does radiation kill cells. Curr. Opin. Chem. Biol. 3, 77-83.
17. Coquelle, A., Pipiras, E., Toledo, F., Buttin, G., and Debatisse, M. (1997). Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89, 215-225.
18. Coquelle, A., Toledo, F., Stern, S., Bieth, A., and Debatisse, M. (1998). A new role for hypoxia in tumor progression: Induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2, 259-265.
19. Dal Cin, P., Kools, P., Sciot, R., De Weven, I., Van Damme, B., Van de Ven, W., and Van den Berghe, H. (1993). Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet. Cytogenet. 68, 85-90.
20. Damm, K., Hemmann, U., Garin-Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., Lauritsch, I., Muller, E., Pascolo, E., Sauter, G., Pantic, M., Martens, U. M., Wenz, C., Lingner, J., Kraut, N., Rettig, W. J., and Schnapp, A. (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958-6968.
21. de Lange, T. (1998). Telomeres and senescence: Ending the debate. Science 279, 334-335.
22. DePinho, R. A. (2000). The age of cancer. Nature 408, 248-254.
23. Duensing, S., Lee, L. Y., Duensing, A., Basile, J., Piboonniyom, S., Gonzalez, S., Crum, C. P., and Münger, K. (2000). The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA 97, 10002-10007.
24. Duensing, S., and Münger, K. (2001). Centrosome abnormalities, genetic instability and carcinogenic progression. Biochim. Biophys. Acta 1471, 81-88.
25. Duesberg, P., Rasnick, D., Li, R., Winters, L., Rausch, C., and Hehlmann, R. (1999). How aneuploidy may cause cancer and genetic instability. Anticancer Res. 19, 4887-4906.
26. Duesberg, P., Stindl, R., and Hehlmann, R. (2001). Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy. Proc. Natl. Acad. Sci. USA 98, 11283-11288.
27. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
28. Egeli, U., Ozkan, L., Tunca, B., Kahraman, S., Cecener, G., Ergul, E., and Engin, K. (2000). The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites. Head Neck 22, 591-598.
29. Eichler, E. E. (2001). Recent duplication domain accretion and the dynamic mutation of the human genome. Trends Genet. 17, 661-669.
30. Emanuel, B. S., and Shaikh, T. H. (2001). Segmental duplications: An 'expanding' role in genomic instability and disease. Nature Rev. Genet. 2, 791-800.
31. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., and Livingston, D. M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
32. Fearon, E. R., Hamilton, S. R., and Vogelstein, B. (1987). Clonal analysis of human colorectal tumors. Science 238, 193-197.
33. Gisselsson, D., Björk, J., Höglund, M., Mertens, F., Dal Cin, P., Åkerman, M., and Mandahl, N. (2001a). Abnormal nuclear shape in solid tumors reflects mitotic instability. Am. J. Pathol. 158, 199-206.
34. Gisselsson, D., Höglund, M., Mertens, F., Johansson, B., Dal Cin, P., Van den Berghe, H., Earnshaw, W. C., Mitelman, F., and Mandahl, N. (1999). The structure and dynamics of ring chromosomes in human neoplastic and non-neoplastic cells. Hum. Genet. 104, 315-325.
35. Gisselsson, D., Höglund, M., Mertens, F., Mitelman, F., and Mandahl, N. (1998). Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 23, 203-212.
36. Gisselsson, D., Jonson, T., Petersén, Å., Strömbeck, B., Dal Cin, P., Höglund, M., Mitelman, F., Mertens, F., and Mandahl, M. (2001b). Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumours. Proc. Natl. Acad. Sci. USA 98, 12683-12688.
37. Gisselsson, D., Jonson, T., Yu., C., Martins, C., Jin, Y., Wiegant, J., Mandahl, N., Mertens, F., and Jin, C. (2002). Centrosome abnormalities, multipolar mitoises, and chromosomal instability in head and neck tumours with dysfunctional telomeres. Br. J. Cancer 87, 202-207.
38. Gisselsson, D., Pettersson, L., Höglund, M., Heidenblad, M., Gorunoval, L., Wiegant, J., Mertens, F., Dal Cin, P., Mitelman, F., and Mandahl, N. (2000). Chromosomal breakage- fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl. Acad. Sci. USA 97, 5357-5362.
39. Gorunova, L., Höglund, M., Andrén-Sandberg, A., Dawiskiba, S., Jin, Y., Mitelman, F., and Johansson, B. (1998). Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23, 81-99.
40. Gorunova, L., Johansson, B., Dawiskiba, S., Andrén-Sandberg, A., Jin, Y., Mandahl, N., Heim, S., and Mitelman, F. (1995). Massive cytogenetic heterogeneity in a pancreatic carcinoma: Fifty-four karyotypically unrelated clones. Genes Chromosomes Cancer 14, 259-266.
41. Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., and Kelland, L. R. (2002). A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity. Mol. Pharmacol. 61, 1154-1162.
42. Griffin, C. A., Hruban, R. H., Morsberger, L. A., Ellingham, T., Long, P. P., Jaffee, E. M., Hauda, K. M., Bohlander, S. K., and Yeo, C. J. (1995). Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res. 55, 2394-2399.
43. Griffith, J. K., Bryant, J. E., Fordyce, C. A., Gilliland, F. D., Joste, N. E., and Moyzis, R. K. (1999). Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res. Treat. 54, 59-64.
44. Gryaznov, S., Pongracz, K., Matray, T., Schultz, R., Pruzan, R., Aimi, J., Chin, A., Harley, C., Shea-Herbert, B., Shay, J., Oshima, Y., Asai, A., and Yamashita, Y. (2001). Telomerase inhibitors: Oligonucleotide phosphoramidates as potential therapeutic agents. Nucleosides Nucleotides Nucleic Acids 20, 401-410.
45. Gumus, G., Sunguroglu, A., Tukun, A., Sayin, D. B., and Bokesoy, I. (2002). Common fragile sites associated with the breakpoints of chromosomal aberrations in hematologic neoplasms. Cancer Genet. Cytogenet. 133, 168-171.
46. Hansemann, D. (1891). Ueber patologische Mitosen. Arch. Pathol. Anat. Phys. Klin. Med. 119, 299-326.
47. Haruki, N., Harano, T., Masuda, A., Kiyono, T., Takahashi, T., Tatematsu, Y., Shimizu, S., Mitsudomi, T., Konishi, H., Osada, H., and Fujii, Y. (2001). Persistent increase in chromosome instability in lung cancer: Possible indirect involvement of p53 inactivation. Am. J. Pathol. 159, 1345-1352.
48. Heim, S. (1996). Clonal chromosome abnormalities in neoplastic cells: Evidence of genetic instability? Cancer Surv. 28, 247-260.
49. Heim, S., Mandahl, N., Kristoffersson, U., Mitelman, F., Rööser, B., Rydholm, A., and Willén, H. (1987). Marker ring chromosome: A new cytogenetic abnormality characterizing lipogenic tumors? Cancer Genet. Cytogenet. 24, 319-326.
50. Heim, S., and Mitelman, F. (1995). "Cancer Cytogenetics." Wiley-Liss, New York.
51. Heim, S., Teixeira, M. A., and Pandis, N. (2001). Are some breast carcinomas polyclonal in origin? J. Pathol. 194, 395-397.
52. Höglund, M., Gisselsson, D., Mandahl, N., Johansson, B., Mertens, F., Mitelman, F., and Sall, T. (2001a). Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer 31, 156-171.
53. Höglund, M., Gisselsson, D., Säll, T., and Mitelman, F. (2002). Coping with complexity: Multivariate analyis of tumor karyotypes. Cancer Genet. Cytogenet. 135, 103-109.
54. Höglund, M., Sall, T., Heim, S., Mitelman, F., Mandahl, N., and Fadl-Elmula, I. (2001b). Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res. 61, 8241-8246.
55. Jin, C., Martins, C., Jin, Y., Wiegant, J., Wennerberg, J., Dictor, M., Gisselsson, D., Strömbeck, B., Fonseca, I., Mitelman, F., Tanke, H. J., Höglund, M., and Mertens, F. (2001a). Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA-FISH. Genes Chromosomes Cancer 30, 161-167.
56. Jin, Y., Höglund, M., Jin, C., Martins, C., Wennerberg, J., Akervall, J., Mandahl, N., Mitelman, F., and Mertens, F. (1998). FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 22, 312-320.
57. Jin, Y., Jin, C., Salemark, L., Martins, C., Wennerberg, J., and Mertens, F. (2000). Centromere cleavage is a mechanism underlying isochromosome formation in skin and head and neck carcinomas. Chromosoma 109, 476-481.
58. Jin, Y., Jin, C., Wennerberg, J., Hoglund, M. N., and Mertens, F. (2001b). Cytogenetic and fluorescence in situ hybridization characterization of chromosome 8 rearrangements in head and neck squamous cell carcinomas. Cancer Genet. Cytogenet. 130, 111-117.
59. Jin, Y., Mertens, F., Mandahl, N., Heim, S., Olegard, C., Wennerberg, J., Biorklund, A., and Mitelman, F. (1993). Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: Influence of culture conditions on karyotypic pattern. Cancer Res. 53, 2140-2146.
60. Karlseder, J., Smogorzewska, A., and de Lange, T. (2002). Senescence induced by altered telomere state, not telomere loss. Science 295, 2446-2449.
61. Knuutila, S., Aalto, Y., Autio, K., Bjorkqvist, A. M., El-Rifai, W., Hemmer, S., Huhta, T., Kettunen, E., Kiuru-Kuhlefelt, S., Larramendy, M. L., Lushnikova, T., Monni, O., Pere, H., Tappen, J., Tarkkanen, M., Varis, A., Wasenius, V. M., Wolf, M., and Zhu, Y. (1999). DNA copy number losses in human neoplasms. Am. J. Pathol. 155, 683-694.
62. Kovacs, G., Fuzesi, L., Emanual, A., and Kung, H. F. (1991). Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer 3, 249-255.
63. Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1997). Genetic instability in colorectal cancers. Nature 386, 623-627.
64. Lengauer, C., Kinzler, K. W., and Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396, 643-649.
65. Levine, D. S., Rabinovitch, P. S., Haggitt, R. C., Blount, P. L., Dean, P. J., Rubin, C. E., and Reid, B. J. (1991a). Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101, 1198-1210.
66. Levine, D. S., Sanchez, C. A., Rabinovitch, P. S., and Reid, B. J. (1991b). Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc. Natl. Acad. Sci. USA 88, 6427-6431.
67. Li, R., Sonik, A., Stindl, R., Rasnick, D., and Duesberg, P. (2000). Aneuploidy vs. gene mutation hypothesis of cancer: Recent study claims mutation but is found to support aneuploidy. Proc. Natl. Acad. Sci. USA 97, 3236-3241.
68. Lingle, W. L., Barrett, S. L., Negron, V. C., D'Assoro, A. B., Boeneman, K., Liu, W., Whitehead, C. M., Reynolds, C., and Salisbury, J. L. (2002). Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 99, 1978-1983.
69. Lingle, W. L., Lutz, W. H., Ingle, J. N., Maihle, N. J., and Salisbury, J. L. (1998). Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity. Proc. Natl. Acad. Sci. USA 95, 2950-2955.
70. Lingle, W. L., and Salisbury, J. L. (1999). Altered centrosome structure is associated with abnormal mitoses in human breast tumors. Am. J. Pathol. 155, 1941-1951.
71. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935.
72. Mandahl, N. (1996). Cytogenetics and molecular genetics of bone and soft tissue tumors. Adv. Cancer Res. 69, 63-99.
73. Mandahl, N., Heim, S., Arheden, K., Rydholm, A., Willén, H., and Mitelman, F. (1988). Rings, dicentrics, and telomeric association in histiocytomas. Cancer Genet. Cytogenet. 30, 23-33.
74. Martins, C., Jin, Y., Jin, C., Wennerberg, J., Hoglund, M., and Mertens, F. (1999). Fluorescent in situ hybridisation (FISH) characterisation of pericentromeric breakpoints on chromosome 5 in head and neck squamous cell carcinomas. Eur. J. Cancer 35, 498-501.
75. McClintock, B. (1938). The production of homozygous deficient tissues with mutant characteristics by means of the aberrant behavior of ring-shaped chromosomes. Genetics 23, 215-376.
76. McClintock, B. (1940). The stability of broken ends of chromosomes in Zea mays. Genetics 26, 234-282.
77. McClintock, B. (1950). The origin and behaviour of mutable loci in maize. Proc. Natl. Acad. Sci. USA 36, 344-355.
78. Meltzer, P. S., Guan, X. Y., and Trent, J. M. (1993). Telomere capture stabilizes chromosome breakage. Nature Genet. 4, 252-255.
79. Mitelman, F. (2002). Mitelman database of chromosome aberration in cancer, http://cgap.nci. nih.gov/Chromosomes/Mitelman.
80. Mitelman, F., Johansson, B., Mandahl, N., and Mertens, F. (1997). Clinical significance of cytogenetic findings in solid tumors. Cancer Genet. Cytogenet. 95, 1-8.
81. Muller, A., and Fishel, R. (2002). Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC). Cancer Invest. 20, 102-109.
82. Nilbert, M., Rydholm, A., Willén, H., Mitelman, F., and Mandahl, N. (1994). MDM2 gene amplification correlates with ring chromosome in soft tissue tumors. Genes Chromosomes Cancer 9, 261-265.
83. Norbury, C. J., and Hickson, I. D. (2001). Cellular responses to DNA damage. Annu. Rev. Pharmacol. Toxicol. 41, 367-401.
84. Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science 194, 23-28.
85. Ohshima, K., Ohgami, A., Matsuoka, M., Etoh, K., Utsunomiya, A., Makino, T., Ishiguro, M., Suzumiya, J., and Kikuchi, M. (1998). Random integration of HTLV-1 provirus: Increasing chromosomal instability. Cancer Lett. 132, 203-212.
86. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., et al. (1996). The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597.
87. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
88. Örndal, C., Rydholm, A., Willén, H., Mitelman, F., and Mandahl, N. (1994). Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet. Cytogenet. 78, 127-137.
89. Pandis, N., Heim, S., Bardi, G., Idvall, I., Mandahl, N., and Mitelman, F. (1993). Chromosome analysis of 20 breast carcinomas: Cytogenetic multiclonality and karyotypic-pathologic correlations. Genes Chromosomes Cancer 6, 51-57.
90. Pandis, N., Teixeira, M. R., Gerdes, A. M., Limon, J., Bardi, G., Andersen, J. A., Idvall, I., Mandahl, N., Mitelman, F., and Heim, S. (1995). Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 76, 250-258.
91. Parada, L. A., Limon, J., Iliszko, M., Czauderna, P., Gisselsson, D., Hoglund, M., Kullendorff, C. M., Wiebe, T., Mertens, F., and Johansson, B. (2000). Cytogenetics of hepatoblastoma: Further characterization of 1q rearrangements by fluorescence in situ hybridization: An international collaborative study. Med. Pediatr. Oncol. 34, 165-170.
92. Pedeutour, F., Forus, A., Coindre, J. M., Berner, J. M., Nicolo, G., Michiels, J. F., Terrier, P., Ranchere-Vince, D., Collin, F., Myklebost, O., and Turc-Carel, C. (1999). Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24, 30-41.
93. Pedeutour, F., Suijkerbuijk, R. F., Van Gaal, J., Van de Klundert, W., Coindre, J. M., Van Haelst, A., Collin, F., Huffermann, K., and Turc-Carel, C. (1993). Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. Cancer Genet. Cytogenet. 66, 133-134.
94. Pedeutour, F., and Turc-Carel, C. (1997). Des chromosomes sans fin: Les chromosomes en anneau. Médecine/Sciences Synthése 13, 1239-1249.
95. Pilotti, S., Della Torre, G., Lavarino, C., Sozzi, G., Minoletti, F., Vergani, B., Azzarelli, A., Rilke, F., and Pierotti, M. A. (1998). Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22. J. Pathol. 185, 188-190.
96. Ragazzini, P., Gamberi, G., Benassi, M. S., Orlando, C., Sestini, R., Ferrari, C., Molendini, L., Sollazzo, M. R., Merli, M., Magagnoli, G., Bertoni, F., Bohling, T., Pazzagli, M., and Picci, P. (1999). Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Cancer Detect. Prev. 23, 129-136.
97. Reid, B. J., Haggitt, R. C., Rubin, C. E., and Rabinovitch, P. S. (1987). Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 93, 1-11.
98. Richards, R. I. (2001). Fragile and unstable chromosomes in cancer: Causes and consequences. Trends Genet. 17, 339-345.
99. Rieker, R. J., Joos, S., Bartsch, C., Willeke, F., Schwarzbach, M., Otano-Joos, M., Ohl, S., Hogel, J., Lehnert, T., Lichter, P., Otto, H. F., and Mechtersheimer, G. (2002). Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int. J. Cancer 99, 68-73.
100. Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. (2001). Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409, 633-637.
101. Rosai, J., Akerman, M., Dal Cin, P., DeWever, I., Fletcher, C. D., Mandahl, N., Mertens, F., Mitelman, F., Rydholm, A., Sciot, R., Tallini, G., Van den Berghe, H., Van de Ven, W., Vanni, R., and Willen, H. (1996). Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: Evaluation of their relationship and differential diagnosis with other adipose tissue tumors a report of the CHAMP Study Group). Am. J. Surg. Pathol. 20, 1182-1189.
102. Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C., and DePinho, R. A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
103. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. (2001). Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nature Genet. 28, 155-159.
104. Sato, N., Mizumoto, K., Nakamura, M., Maehara, N., Minamishima, Y. A., Nishio, S., Nagai, E., and Tanaka, M. (2001). Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet. Cytogenet. 126, 13-19.
105. Sato, N., Mizumoto, K., Nakamura, M., Nakamura, K., Kusumoto, M., Niiyama, H., Ogawa, T., and Tanaka, M. (1999). Centrosome abnormalities in pancreatic ductal carcinoma. Clin. Cancer Res. 5, 963-970.
106. Saunders, W. S., Shuster, M., Huang, X., Gharaibeh, B., Enyenihi, A. H., Petersen, I., and Gollin, S. M. (2000). Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc. Natl. Acad. Sci. USA 97, 303-308.
107. Sawyer, J. R., Husain, M., Pravdenkova, S., Krisht, A., and Al-Mefty, O. (2000). A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients. Cancer 88, 440-453.
108. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
109. Schuuring, E. (1995). The involvement of the chromosome 11q13 region in human malignances: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene 159, 83-96.
110. Shea-Herbert, B., Pongracz, K., Shay, J. W., and Gryaznov, S. M. (2002). Oligonucleotide N3′→P5′ phosphoramidates as efficient telomerase inhibitors. Oncogene 21, 638-642.
111. Shimura, M., Onozuka, Y., Yamaguchi, T., Hatake, K., Takaku, F., and Ishizaka, Y. (1999). Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus. Cancer Res. 59, 2259-2264.
112. Shono, M., Sato, N., Mizumoto, K., Maehara, N., Nakamura, M., Nagai, E., and Tanaka, M. (2001). Stepwise progression of centrosome defects associated with local tumor growth and metastatic process of human pancreatic carcinoma cells transplanted orthotopically into nude mice. Lab. Invest. 81, 945-952.
113. Shuster, M. I., Han, L., Le Beau, M. M., Davis, E., Sawicki, M., Lese, C. M., Park, N. H., Colicelli, J., and Gollin, S. M. (2000). A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11 q 13 amplification. Genes Chromosomes Cancer 28, 153-163.
114. Simon, R., Desper, R., Papadimitriou, C. H., Peng, A., Alberts, D. S., Taetle, R., Trent, J. M., and Schaffer, A. A. (2000). Chromosome abnormalities in ovarian adenocarcinoma. III. Using breakpoint data to infer and test mathematical models for oncogenesis. Genes Chromosomes Cancer 28, 106-120.
115. Smedley, D., Sidhar, S., Birdsall, S., Bennett, D., Herlyn, M., Cooper, C., and Shipley, J. (2000). Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 28, 121-125.
116. Smith, K. A., Agarwal, M. L., Chernov, M. V., Chernova, O. B., Deguchi, Y., Ishizaka, Y., Patterson, T. E., Poupon, M. F., and Stark, G. R. (1995). Regulation and mechanisms of gene amplification. Phil. Trans. R. Soc. Lond. B Biol. Sci. 347, 49-56.
117. Smith, K. A., Stark, M. B., Gorman, P. A., and Stark, G. R. (1992). Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc. Natl. Acad. Sci. USA 89, 5427-5431.
118. Spruck, C. H., Won, K. A., and Reed, S. I. (1999). Deregulated cyclin E induces chromosome instability. Nature 401, 297-300.
119. Stary, A., and Sarasin, A. (2002). The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84, 49-60.
120. Sternes, K. L., Vig, B. K., and Garner, D. L. (1991). Cytogenetic variability and kinetochore proteins: Comparison among populations derived from single-cell cultures. Cancer Genet. Cytogenet. 56, 73-82.
121. Tallini, G., Dal Cin, P., Rhoden, K. J., Chiapetta, G., Manfioletti, G., Giancotti, V., Fusco, A., Van den Berghe, H., and Sciot, R. (1997). Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: Immunohistochemical reactivity correlates with karyotypic alterations. Am. J. Pathol. 151, 37-43.
122. Teixeira, M. R., Pandis, N., Bardi, G., Andersen, J. A., Mandahl, N., Mitelman, F., and Heim, S. (1994). Cytogenetic analysis of multifocal breast carcinomas: Detection of karyotypically unrelated clones as well as clonal similarities between tumour foci. Br. J. Cancer 70, 922-927.
123. Toguchida, J., Yamaguchi, T., Richie, B., Beauchamp, R. L., Dayton, S. H., Herrera, G. E., Yamamuro, T., Kotoura, Y., Sasaki, M. S., Little, J. B., Weichselbaum, R. R., Ishizaki, K., and Yandell, D. W. (1992). Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res. 52, 6194-6199.
124. Tunca, B., Cecener, G., Gebitekin, C., Egeli, U., Ediz, B., and Ercan, I. (2002). Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression. Teratogen. Carcinogen. Mutagen. 22, 205-215.
125. Tunca, B., Egeli, U., Zorluoglu, A., Yilmazlar, T., Yerci, O., and Kizil, A. (2000). The expression frequency of common fragile sites and genetic predisposition to colon cancer. Cancer Genet. Cytogenet. 119, 139-145.
126. Werness, B. A., Levine, A. J., and Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79.
127. Yan, P., Benhattar, J., Coindre, J. M., and Guillou, L. (2002). Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Int. J. Cancer 98, 851-856.
128. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. (1992). Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948.
129. Yunis, J. J., and Soreng, A. L. (1984). Constitutive fragile sites and cancer. Science 226, 1199-1204.
130. Zhang, F., Deng, Z., Jia, Z., Wei, Y., Fan, J., and Wu, H. (2001). Telomere length and DCC gene mRNA expression of human large intestine cancers. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18, 187-190.
131. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., and Sen, S. (1998). Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet. 20, 189-193.
132. Zhou, X., Benson, K. F., Ashar, H. R., and Chada, K. (1995). Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376, 771-774.